Ardelyx: Limited Pipeline, Rising Costs, And Uncertain Growth Ahead (Downgrade)Seeking Alpha • 02/24/25
Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 02/20/25
Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025GlobeNewsWire • 01/30/25
Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic PrioritiesGlobeNewsWire • 01/13/25
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewsWire • 11/20/24
Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 10/31/24
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 10/31/24
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology's (ACG) Annual MeetingGlobeNewsWire • 10/28/24
ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 10/23/24